Multiple Sclerosis PathoGenesis

  1. Mitochondrial damage and histotoxic Hypoxia: a pathway of tissue injury in Inflammatory Brain Disease?
    Acta NeuroPathol (Berl) 2005 Jan 11

  2. Pathogenesis of Brain and Spinal Cord Atrophy in Multiple Sclerosis
    J NeuroImaging 2004 Jul;14(3 Suppl):5S-10S

  3. White Matter T1 relaxation time Histograms and Cerebral Atrophy in Multiple Sclerosis
    J Neurol Sci 2002 May 15;197(1-2):45-50

  4. Control of Glial Immune function by Neurons
    Glia 2001 Nov;36(2):191-9

  5. The role of T-Cell-mediated mechanisms in Virus infections of the Nervous System
    Curr Top Microbiol Immunol 2001;253:219-45

  6. The pathogenesis of Multiple Sclerosis: a commentary
    Clin Neurol NeuroSurg 2001 Dec 1;102(4):191-194

  7. The ExtraCellular Matrix in Multiple Sclerosis: an update
    Braz J Med Biol Res 2001 May;34(5):603-609

  8. Bulk Listings - The Blood-Brain Barrier in Multiple Sclerosis
    Oldest,   Newer,   Newest

  9. Bulk List
    Humoral Immunity In Multiple Sclerosis

  10. Bulk List
    The Complement System

  11. Bulk List
    Structure & function of Myelin Oligodendrocyte GlycoProtein (MOG)

  12. Bulk List
    HLA-DR-restricted presentation by human B-Cells

  13. Bulk List
    Glia Cells in Multiple Sclerosis

  14. Bulk List Must Read
    Anoxic and Ischemic injury of Myelinated CNS Axons

  15. Bulk List
    Matrix MetalloProteinases in Multiple Sclerosis

  16. Bulk Listing Must Read
    Adhesion Molecules in Multiple Sclerosis

  17. Bulk List - Wallerian Degeneration causes Axonal loss in Multiple Sclerosis
    Oldest,   Newer

  18. Oxidative damage to Mitochondrial DNA and activity of Mitochondrial enzymes in chronic active lesions of Multiple Sclerosis
    J Neurol Sci 2000 Aug 15;177(2):95-103

  19. Defective regulation of IFN-gamma and IL-12 by endogenous IL-10 in Progressive MS
    Neurology 2000 Jul 25;55(2):192-8

  20. Heterogeneity of Multiple Sclerosis lesions: implications for the PathoGenesis of DeMyelination
    Ann Neurol 2000 Jun;47(6):707-17

  21. Total Brain N-AcetylAspartate: New measure of MS disease load
    Neurology 2000 Jan 11;54(1):15-9

  22. Three mechanisms underlying the clinical course of MS
    Ann Neurol 1999 Sep;46(3):296-304

  23. PathoGenesis of Multiple Sclerosis: a critical reappraisal Must Read
    Acta Neuropathol (Berl) 1986;71(1-2):1-10

  24. ImmunoPathology concepts of Multiple Sclerosis lesions
    Springer Semin Immunopathol 1995;17(1):77-87

  25. Patterns of Oligodendroglia pathology in Multiple Sclerosis
    Brain 1994 Dec;117 ( Pt 6):1311-22

  1. A study of the mechanisms of Normal-Appearing White Matter damage in Multiple Sclerosis using Diffusion Tensor imaging - Evidence of Wallerian Degeneration
    J Neurol 2003 Mar;250(3):287-92

  2. Increased differentiation of IntraCranial White Matter lesions by multispectral 3D-tissue segmentation: preliminary results
    Magn Reson Imaging 2001 Feb;19(2):207-18

  3. Insights into the Etiology and PathoGenesis of Multiple Sclerosis
    Immunol Cell Biol 1998 Feb;76(1):47-54

  4. The controversy surrounding the PathoGenesis of the MS lesion
    Mayo Clin Proc 1997 Jul;72(7):665-78

  5. Multiple Sclerosis: from a Myelin point of view
    J NeuroSci Res 1996 Sep 15;45(6):647-54

  6. Role of Macrophages/Microglia in Multiple Sclerosis and EAE
    J Mol Med 1997 Mar;75(3):165-73

  7. The PathoGenesis and therapy of Multiple Sclerosis is based upon the requirement of a combination of Myelin Antigens for AutoImmune DeMyelination
    J NeuroImmunol 1982 Jan;2(1):83-91

  8. Oxidative stress and ExcitoToxicity: a therapeutic issue in Multiple Sclerosis?
    Mult Scler 2008 Jan;14(1):22-34